Sjögren's drug mystery: biopsy study reveals how ianalumab acts on salivary glands
NCT ID NCT05124925
First seen Feb 02, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study looked at how the drug ianalumab affects the salivary glands of people with Sjögren's syndrome, an autoimmune disease causing dry eyes and mouth. Researchers took small tissue samples (biopsies) from 21 adults to measure changes in immune cells and check for side effects. The goal was to understand the drug's mechanism, not to test if it works as a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJOGREN SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Brest, 29200, France
Conditions
Explore the condition pages connected to this study.